Related Experiment Videos
A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid
Abstract:
Mitochondrial monoamine oxidase (MAO), type B, has been implicated in the etiology of schizophrenia. We have found the phospholipid, phosphatidylserine (PS) to be a highly specific inhibitor of MAO-B, which has led us to postulate that the PS-MAO interaction might offer a basis for the lower MAO levels observed in platelets from certain schizophrenic populations. In this study we compared platelet MAO activity with phospholipid composition in a group of normals and chronic paranoid schizophrenics. The phospholipids in platelets and erythrocytes were extracted and separated by high-performance liquid chromatography into major classes phosphatidylcholine (PC), phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol and PS. The paranoid subjects showed statistically significantly lower MAO activity as well as higher mean levels of PS and lower levels of PC in both platelets and erythrocytes, consistent with our hypothesis. The Ca2+-stimulated synthesis of serine-lipid in platelets was also monitored by incorporation of radioisotope into lipid extracts from 14C-labelled serine substrate, and no significant differences were found between subjects groups with respect to this parameter.
Insights
Schizophrenia patients showed lower monoamine oxidase (MAO) activity and altered phospholipid levels, specifically higher phosphatidylserine (PS) and lower phosphatidylcholine (PC). This supports the hypothesis that PS inhibits MAO-B, potentially explaining reduced MAO levels in schizophrenia.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Mitochondrial monoamine oxidase (MAO) type B is implicated in schizophrenia etiology.
- Phosphatidylserine (PS) is a specific inhibitor of MAO-B.
- The PS-MAO interaction may explain lower MAO levels in schizophrenic populations.
Purpose of the Study:
- To compare platelet MAO activity and phospholipid composition in normal individuals and chronic paranoid schizophrenics.
- To investigate the role of phosphatidylserine (PS) in the observed lower MAO levels in schizophrenia.
Main Methods:
- Platelet and erythrocyte phospholipids were extracted and separated using high-performance liquid chromatography (HPLC).
- Major phospholipid classes including phosphatidylcholine (PC) and phosphatidylserine (PS) were quantified.
- MAO activity in platelets was measured.
- Ca2+-stimulated serine-lipid synthesis was monitored using 14C-labeled serine.
Main Results:
- Schizophrenic subjects exhibited significantly lower platelet MAO activity compared to controls.
- Elevated mean levels of phosphatidylserine (PS) and reduced levels of phosphatidylcholine (PC) were observed in both platelets and erythrocytes of paranoid subjects.
- No significant differences in Ca2+-stimulated serine-lipid synthesis were found between the groups.
Conclusions:
- The findings support the hypothesis that phosphatidylserine (PS) inhibition of MAO-B contributes to lower MAO activity in certain schizophrenic populations.
- Alterations in phospholipid composition, particularly PS and PC, may be linked to the pathophysiology of schizophrenia.
- Further research into the PS-MAO-B interaction could offer insights into schizophrenia treatment strategies.